000 | 01595 a2200529 4500 | ||
---|---|---|---|
005 | 20250517162439.0 | ||
264 | 0 | _c20190102 | |
008 | 201901s 0 0 eng d | ||
022 | _a2041-1723 | ||
024 | 7 |
_a10.1038/ncomms15949 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHassan, U | |
245 | 0 | 0 |
_aA point-of-care microfluidic biochip for quantification of CD64 expression from whole blood for sepsis stratification. _h[electronic resource] |
260 |
_bNature communications _c07 2017 |
||
300 |
_a15949 p. _bdigital |
||
500 | _aPublication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aBiomarkers _xblood |
650 | 0 | 4 | _aFlow Cytometry |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLeukocyte Count |
650 | 0 | 4 |
_aMicrofluidics _xinstrumentation |
650 | 0 | 4 |
_aNeutrophils _xcytology |
650 | 0 | 4 | _aPoint-of-Care Systems |
650 | 0 | 4 |
_aReceptors, IgG _xblood |
650 | 0 | 4 | _aSensitivity and Specificity |
650 | 0 | 4 |
_aSepsis _xblood |
700 | 1 | _aGhonge, T | |
700 | 1 | _aReddy, B | |
700 | 1 | _aPatel, M | |
700 | 1 | _aRappleye, M | |
700 | 1 | _aTaneja, I | |
700 | 1 | _aTanna, A | |
700 | 1 | _aHealey, R | |
700 | 1 | _aManusry, N | |
700 | 1 | _aPrice, Z | |
700 | 1 | _aJensen, T | |
700 | 1 | _aBerger, J | |
700 | 1 | _aHasnain, A | |
700 | 1 | _aFlaugher, E | |
700 | 1 | _aLiu, S | |
700 | 1 | _aDavis, B | |
700 | 1 | _aKumar, J | |
700 | 1 | _aWhite, K | |
700 | 1 | _aBashir, R | |
773 | 0 |
_tNature communications _gvol. 8 _gp. 15949 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/ncomms15949 _zAvailable from publisher's website |
999 |
_c27332507 _d27332507 |